Ed Schutter has over thirty years of pharmaceutical industry experience and is currently CEO of Arbor Pharmaceuticals. Ed was previously President of Sciele (Shionogi) Pharmaceuticals prior to joining Arbor. Prior to Sciele, Ed served as VP of Global Business development at Solvay Pharmaceuticals based in Basel, Switzerland. He also held several senior management roles at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, GA. Ed is a registered pharmacist with a BS in Pharmaceutical Sciences from Mercer University, an MBA from Kennesaw State University and has completed graduate studies in International Business at Njienrode University, Amsterdam, Netherlands. He is currently a board member of Arbor, Vitruvias Therapeutics, Terrascend (TER.CN) and Establishment Labs (ESTA, NASDQ) and has been a previous board member of Knight Therapeutics (GUD.TO), Mercer University Board of Trustees, American Diabetes Association, American Heart Association as well as several other private pharma companies and nonprofit organizations.